Sol-Gel Technologies(SLGL),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

SLGL Sol-Gel Technologies

Closed 01-23 16:00:00 EST

58.44

+0.94

+1.63%

盘后60.00

+1.56+2.67%

19:15 EST

High63.03	Low48.26	Vol25.49K
Open53.62	D1 Closing57.50	Amplitude25.69%
Mkt Cap162.80M	Tradable Cap40.29M	Total Shares2.79M
T/O1.47M	T/O Rate3.70%	Tradable Shares689.35K
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"SLGL","market":"US","secType":"STK","nameCN":"Sol-Gel Technologies","latestPrice":58.44,"timestamp":1769202000000,"preClose":57.5,"halted":0,"volume":25494,"hourTrading":{"tag":"盘后","latestPrice":60,"preClose":58.44,"latestTime":"19:15 EST","volume":413,"amount":24765.96,"timestamp":1769213753690,"change":1.56,"changeRate":0.026694,"amplitude":0.026694},"delay":0,"changeRate":0.016347826086956483,"floatShares":689345,"shares":2785787,"eps":-3.225688,"marketStatus":"Closed","change":0.94,"latestTime":"01-23 16:00:00 EST","open":53.62,"high":63.03,"low":48.26,"amount":1469571.54708,"amplitude":0.25687,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-3.225688,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1769418000000},"marketStatusCode":5,"adr":0,"adrRate":0,"listingDate":1517461200000,"exchange":"NASDAQ","adjPreClose":57.5,"postHourTrading":{"tag":"盘后","latestPrice":60,"preClose":58.44,"latestTime":"19:15 EST","volume":413,"amount":24765.96,"timestamp":1769213753690,"change":1.56,"changeRate":0.026694,"amplitude":0.026694},"volumeRatio":1.406892,"impliedVol":1.504,"impliedVolPercentile":0.9857},"requestUrl":"/m/hq/s/SLGL","defaultTab":"news","newsList":[{"id":"2605286752","title":"Opaleye Management Inc. Acquires Common Shares of Sol Gel Technologies Ltd","url":"https://stock-news.laohu8.com/highlight/detail?id=2605286752","media":"Reuters","labels":["shareholding","insiderTrades"],"top":1,"itemType":null,"share":"https://ttm.financial/m/news/2605286752?lang=en_us&edition=fundamental","pubTime":"2026-01-24 06:43","pubTimestamp":1769208205,"startTime":"0","endTime":"0","summary":"Opaleye Management Inc. has reported the acquisition of common shares of Sol Gel Technologies Ltd. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sol Gel Technologies Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on January 23, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260123:nNDLLnp8S:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Opaleye Management Inc. Acquires Common Shares of Sol Gel Technologies Ltd","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","SLGL"],"gpt_icon":0},{"id":"2605282854","title":"Major Investor Quietly Boosts Stake in Sol-Gel Technologies With Fresh Buy","url":"https://stock-news.laohu8.com/highlight/detail?id=2605282854","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605282854?lang=en_us&edition=fundamental","pubTime":"2026-01-24 10:01","pubTimestamp":1769220119,"startTime":"0","endTime":"0","summary":"New insider activity at Sol-Gel Technologies ( ($SLGL) ) has taken place on January 23, 2026. Significant shareholder Opaleye Management Inc. has i...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/insider-trading/major-investor-quietly-boosts-stake-in-sol-gel-technologies-with-fresh-buy-insider-trading-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/insider-trading/major-investor-quietly-boosts-stake-in-sol-gel-technologies-with-fresh-buy-insider-trading-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SLGL","BK4007"],"gpt_icon":0},{"id":"2604319723","title":"Sol-Gel Technologies Is Maintained at Buy by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2604319723","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604319723?lang=en_us&edition=fundamental","pubTime":"2026-01-20 19:54","pubTimestamp":1768910040,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/SLGL/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  January 20, 2026 06:54 ET (11:54 GMT)","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SLGL"],"gpt_icon":0},{"id":"2604219733","title":"Sol-Gel Technologies: Upside-Driven Buy on SGT-610’s Orphan Gorlin Syndrome Opportunity and Repriced Peak Sales Potential","url":"https://stock-news.laohu8.com/highlight/detail?id=2604219733","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604219733?lang=en_us&edition=fundamental","pubTime":"2026-01-20 19:38","pubTimestamp":1768909130,"startTime":"0","endTime":"0","summary":"In a report released today, Ram Selvaraju from H.C. Wainwright maintained a Buy rating on Sol-Gel Technologies, with a price target of $110.00. Ram...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/sol-gel-technologies-upside-driven-buy-on-sgt-610s-orphan-gorlin-syndrome-opportunity-and-repriced-peak-sales-potential-ratings?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/sol-gel-technologies-upside-driven-buy-on-sgt-610s-orphan-gorlin-syndrome-opportunity-and-repriced-peak-sales-potential-ratings?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SLGL","SKIS"],"gpt_icon":0},{"id":"2603981442","title":"Here's Why We're Not At All Concerned With Sol-Gel Technologies' (NASDAQ:SLGL) Cash Burn Situation","url":"https://stock-news.laohu8.com/highlight/detail?id=2603981442","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603981442?lang=en_us&edition=fundamental","pubTime":"2026-01-15 20:36","pubTimestamp":1768480562,"startTime":"0","endTime":"0","summary":"Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-slgl/sol-gel-technologies/news/heres-why-were-not-at-all-concerned-with-sol-gel-technologie","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-slgl/sol-gel-technologies/news/heres-why-were-not-at-all-concerned-with-sol-gel-technologie","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["GPIQ","USAW.SI","NQmain","QQQM","QID","QYLG","SQQQ","QLD","QYLD","MNQmain","BK4007","SLGL","QQQY","TSYW.SI","TQQQ","PSQ","QQQE","USJW.SI","NVIW.SI",".IXIC","QQQJ"],"gpt_icon":1},{"id":"2601055848","title":"Opaleye Management Inc. Reports Acquisition of Common Shares of Sol Gel Technologies Ltd","url":"https://stock-news.laohu8.com/highlight/detail?id=2601055848","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601055848?lang=en_us&edition=fundamental","pubTime":"2026-01-07 05:06","pubTimestamp":1767733578,"startTime":"0","endTime":"0","summary":"Opaleye Management Inc. has reported an acquisition of common shares of Sol Gel Technologies Ltd. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sol Gel Technologies Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on January 06, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260106:nNDL68Vhq9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Opaleye Management Inc. Reports Acquisition of Common Shares of Sol Gel Technologies Ltd","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SLGL","BK4007"],"gpt_icon":0},{"id":"2595758456","title":"Opaleye Management Inc. Reports Acquisition of Sol Gel Technologies Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2595758456","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2595758456?lang=en_us&edition=fundamental","pubTime":"2025-12-30 05:06","pubTimestamp":1767042376,"startTime":"0","endTime":"0","summary":"Opaleye Management Inc., a beneficial owner, has reported the acquisition of common shares of Sol Gel Technologies Ltd. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sol Gel Technologies Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on December 29, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251229:nNDL9ZGcRV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Opaleye Management Inc. Reports Acquisition of Sol Gel Technologies Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","SLGL"],"gpt_icon":0},{"id":"2593481009","title":"Sol-Gel Technologies Price Target Maintained With a $50.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2593481009","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593481009?lang=en_us&edition=fundamental","pubTime":"2025-12-22 19:33","pubTimestamp":1766403180,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/SLGL/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  December 22, 2025 06:33 ET (11:33 GMT)","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SLGL"],"gpt_icon":0},{"id":"2592197428","title":"Opaleye Management Inc. Reports Acquisition of Sol Gel Technologies Ltd. Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2592197428","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592197428?lang=en_us&edition=fundamental","pubTime":"2025-12-20 05:06","pubTimestamp":1766178366,"startTime":"0","endTime":"0","summary":"Opaleye Management Inc., a 10% owner, reported the acquisition of common shares of Sol Gel Technologies Ltd. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sol Gel Technologies Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on December 19, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251219:nNDL6yLVpy:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Opaleye Management Inc. Reports Acquisition of Sol Gel Technologies Ltd. Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","SLGL"],"gpt_icon":0},{"id":"2592948586","title":"Sol-Gel to End SGT-210 Trial in Darier Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2592948586","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592948586?lang=en_us&edition=fundamental","pubTime":"2025-12-18 04:08","pubTimestamp":1766002118,"startTime":"0","endTime":"0","summary":"Sol-Gel Technologies  said Wednesday data from its phase 1b trial of SGT-210 in Darier Disease did not show differentiation between SGT-210 and vehicle on efficacy following unblinding.\"The study did not demonstrate a signal of superiority of active treatment versus vehicle,\" said Executive Chairman Mori Arkin. \"We have therefore decided not to advance to the next stage of development in this indication.\"Arkin said the firm plans to pursue \"very\" small, low-cost feasibility studies in other areas where the mechanistic rationale for SGT-210 is strong.Shares of Sol-Gel were over 2% lower in recent trading.Price: 41.25, Change: -0.88, Percent Change: -2.08","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["SLGL","BK4007"],"gpt_icon":0},{"id":"2592591088","title":"Why Is Small Cap Sol-Gel Tech Stock Falling Today?","url":"https://stock-news.laohu8.com/highlight/detail?id=2592591088","media":"Benzinga_recent_news","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592591088?lang=en_us&edition=fundamental","pubTime":"2025-12-18 02:47","pubTimestamp":1765997220,"startTime":"0","endTime":"0","summary":"Sol-Gel Technologies ends development of SGT-210 in Darier disease after Phase 1b data show no efficacy versus vehicle.","market":"sh","thumbnail":"https://cdn.benzinga.com/files/images/story/2025/12/17/Medical-Development-Laboratory-Caucasian.jpeg?optimize=medium&dpr=2&auto=webp&width=240","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2025/12/17/Medical-Development-Laboratory-Caucasian.jpeg?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/news/health-care/25/12/49459762/why-is-small-cap-sol-gel-tech-stock-falling-today","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/health-care/25/12/49459762/why-is-small-cap-sol-gel-tech-stock-falling-today","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_recent_news","symbols":["BK4007","SLGL"],"gpt_icon":0},{"id":"2592992310","title":"Sol Gel Technologies Ltd - Phase 1B Study of Sgt-210 Shows No Differentiation From Vehicle","url":"https://stock-news.laohu8.com/highlight/detail?id=2592992310","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592992310?lang=en_us&edition=fundamental","pubTime":"2025-12-17 20:00","pubTimestamp":1765972803,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251217:nTUA6RCC4T:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SLGL","BK4007"],"gpt_icon":0},{"id":"2592923179","title":"Sol Gel Technologies Ltd - Sol-Gel Decides Not to Advance Sgt-210 to Next Development Stage","url":"https://stock-news.laohu8.com/highlight/detail?id=2592923179","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592923179?lang=en_us&edition=fundamental","pubTime":"2025-12-17 20:00","pubTimestamp":1765972803,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251217:nTUA6RCC4T:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","SLGL"],"gpt_icon":0},{"id":"2592199231","title":"Sol Gel Technologies Ltd - Continue to Prioritize Phase 3 Program of Sgt-610 in Gorlin Syndrome","url":"https://stock-news.laohu8.com/highlight/detail?id=2592199231","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592199231?lang=en_us&edition=fundamental","pubTime":"2025-12-17 20:00","pubTimestamp":1765972803,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251217:nTUA6RCC4T:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SLGL","BK4007"],"gpt_icon":0},{"id":"2592516992","title":"Sol-Gel Provides Update Following Unblinding of Phase 1b Study of SGT-210 in Darier Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2592516992","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592516992?lang=en_us&edition=fundamental","pubTime":"2025-12-17 20:00","pubTimestamp":1765972800,"startTime":"0","endTime":"0","summary":"NESS ZIONA, Israel, Dec.  17, 2025  (GLOBE NEWSWIRE) -- Sol-Gel Technologies, Ltd.(NASDAQ: SLGL), a dermatology company, pioneering treatments for patients with rare and severe skin conditions, today ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/12/17/3206873/0/en/Sol-Gel-Provides-Update-Following-Unblinding-of-Phase-1b-Study-of-SGT-210-in-Darier-Disease.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SLGL","BK4007"],"gpt_icon":0},{"id":"2592937920","title":"Opaleye Management Inc. Reports Acquisition of Sol-Gel Technologies Ltd. Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2592937920","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592937920?lang=en_us&edition=fundamental","pubTime":"2025-12-17 05:06","pubTimestamp":1765919168,"startTime":"0","endTime":"0","summary":"Opaleye Management Inc. has reported the acquisition of common shares of Sol Gel Technologies Ltd. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sol Gel Technologies Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on December 16, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251216:nNDL9JHBLQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Opaleye Management Inc. Reports Acquisition of Sol-Gel Technologies Ltd. Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","SLGL"],"gpt_icon":0},{"id":"2590321772","title":"Opaleye Management Acquires Common Shares of Sol Gel Technologies Ltd","url":"https://stock-news.laohu8.com/highlight/detail?id=2590321772","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590321772?lang=en_us&edition=fundamental","pubTime":"2025-12-10 05:12","pubTimestamp":1765314762,"startTime":"0","endTime":"0","summary":"Opaleye Management Inc., a beneficial owner, has reported the acquisition of common shares of Sol Gel Technologies Ltd. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sol Gel Technologies Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on December 09, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251209:nNDL9WbbN3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Opaleye Management Acquires Common Shares of Sol Gel Technologies Ltd","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","SLGL"],"gpt_icon":0},{"id":"2588271310","title":"Opaleye Management Inc. Reports Acquisition of Sol Gel Technologies Ltd. Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2588271310","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588271310?lang=en_us&edition=fundamental","pubTime":"2025-12-04 06:39","pubTimestamp":1764801572,"startTime":"0","endTime":"0","summary":"Opaleye Management Inc., a beneficial owner, has reported the acquisition of common shares of Sol Gel Technologies Ltd. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sol Gel Technologies Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on December 03, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251203:nNDL91K9dy:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Opaleye Management Inc. Reports Acquisition of Sol Gel Technologies Ltd. Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SLGL","BK4007"],"gpt_icon":0},{"id":"2586260131","title":"Opaleye Management Inc. Reports Acquisition of Sol-Gel Technologies Ltd. Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2586260131","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586260131?lang=en_us&edition=fundamental","pubTime":"2025-11-27 05:06","pubTimestamp":1764191174,"startTime":"0","endTime":"0","summary":"Opaleye Management Inc., a beneficial owner, reported the acquisition of common shares of Sol Gel Technologies Ltd. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sol Gel Technologies Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on November 26, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251126:nNDL9s6tjK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Opaleye Management Inc. Reports Acquisition of Sol-Gel Technologies Ltd. Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","SLGL"],"gpt_icon":0},{"id":"2585125279","title":"Opaleye Management Inc. Reports Acquisition of Sol-Gel Technologies Ltd. Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2585125279","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585125279?lang=en_us&edition=fundamental","pubTime":"2025-11-22 05:06","pubTimestamp":1763759191,"startTime":"0","endTime":"0","summary":"Opaleye Management Inc., as a beneficial owner, has reported the acquisition of common shares of Sol Gel Technologies Ltd. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sol Gel Technologies Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on November 21, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251121:nNDL5zwYjf:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Opaleye Management Inc. Reports Acquisition of Sol-Gel Technologies Ltd. Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SLGL","BK4007"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.sol-gel.com","stockEarnings":[{"period":"1week","weight":-0.1582},{"period":"1month","weight":0.3319},{"period":"3month","weight":0.4744},{"period":"6month","weight":4.2273},{"period":"1year","weight":5.396},{"period":"ytd","weight":0.3645}],"compareEarnings":[{"period":"1week","weight":-0.0047},{"period":"1month","weight":0.0015},{"period":"3month","weight":0.0173},{"period":"6month","weight":0.0814},{"period":"1year","weight":0.1361},{"period":"ytd","weight":0.0104}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Sol-Gel Technologies Ltd., together with its subsidiary Sol-Gel Technologies Inc., develops topical dermatological drugs for patients with severe skin conditions in Israel. The company offers Twyneo, a once-daily, non-antibiotic topical cream for the treatment of acne vulgaris; and Epsolay, a once-daily topical cream for the treatment of papulopustular (subtype II) rosacea. It also develops SGT-610 that is in Phase 3 clinical trials for the treatment of Gorlin Syndrome; and SGT-210, which has completed Phase I clinical trial, to treat rare hyperkeratinization disorders, such as Darier, PC, PPK, Olmsted, etc. In addition, the company is also involved in the development of generic topical dermatological drug products. It has collaboration with Padagis Israel Pharmaceuticals Ltd; and license agreements with Galderma Holding SA and Searchlight Pharma Inc. Sol-Gel Technologies Ltd. was incorporated in 1997 and is headquartered in Ness Ziona, Israel.","yearOnYearQuotes":[{"month":1,"riseRate":0.375,"avgChangeRate":0.031906},{"month":2,"riseRate":0.285714,"avgChangeRate":-0.077333},{"month":3,"riseRate":0.25,"avgChangeRate":-0.056039},{"month":4,"riseRate":0.375,"avgChangeRate":0.000899},{"month":5,"riseRate":0.5,"avgChangeRate":0.013217},{"month":6,"riseRate":0.625,"avgChangeRate":-0.011897},{"month":7,"riseRate":0.5,"avgChangeRate":0.06768},{"month":8,"riseRate":0.5,"avgChangeRate":0.113954},{"month":9,"riseRate":0.5,"avgChangeRate":-0.011791},{"month":10,"riseRate":0.25,"avgChangeRate":-0.064677},{"month":11,"riseRate":0.625,"avgChangeRate":0.040189},{"month":12,"riseRate":0.375,"avgChangeRate":0.187906}],"exchange":"NASDAQ","name":"Sol-Gel Technologies","nameEN":"Sol-Gel Technologies"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Sol-Gel Technologies(SLGL),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Sol-Gel Technologies(SLGL) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Sol-Gel Technologies,SLGL,Sol-Gel Technologies股票,Sol-Gel Technologies股票老虎,Sol-Gel Technologies股票老虎国际,Sol-Gel Technologies行情,Sol-Gel Technologies股票行情,Sol-Gel Technologies股价,Sol-Gel Technologies股市,Sol-Gel Technologies股票价格,Sol-Gel Technologies股票交易,Sol-Gel Technologies股票购买,Sol-Gel Technologies股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Sol-Gel Technologies(SLGL),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Sol-Gel Technologies(SLGL) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction